EPA’s Proposed Endocrine List Has Potential Upside for Certain Company Stocks

EPA has released a list of 134 substances that it proposes to screen for potential endocrine disrupting effects. The agency also has proposed draft policies that it will use to order the testing process, minimize duplicative testing, and to promote equitable cost-sharing. Public comments are due December 17. The 134 chemicals include “a large number of pesticides, two perfluorocarbon compounds (PFCs), and three pharmaceuticals (erythromycin, nitroglycerin, and quinoline),” EPA says. The list also includes  “an array of other chemicals...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers